OWM
GILD icon

Opes Wealth Management’s Gilead Sciences GILD Stock Holding History

Opes Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23.6M Hold
169,652
– – 3.89% 4
2025
Q4 		$20.8M Sell
169,652
-1,365
-0.8% -$166K 3.4% 4
2025
Q3 		$19M Hold
171,017
– – 3.28% 4
2025
Q2 		$19M Buy
171,017
+13,690
+9% +$1.46M 3.37% 5
2025
Q1 		$17.6M Buy
157,327
+118
+0.1% +$12.2K 3.56% 4
2024
Q4 		$14.5M Buy
157,209
+120
+0.1% +$10.8K 2.98% 5
2024
Q3 		$13.2M Sell
157,089
-1,662
-1% -$127K 2.53% 5
2024
Q2 		$10.9M Buy
158,751
+244
+0.2% +$16.3K 2.27% 8
2024
Q1 		$11.6M Buy
158,507
+531
+0.3% +$40.8K 2.68% 5
2023
Q4 		$12.8M Sell
157,976
-277
-0.2% -$21.6K 3.07% 5
2023
Q3 		$11.9M Buy
158,253
+676
+0.4% +$52K 3.29% 5
2023
Q2 		$12.1M Buy
157,577
+261
+0.2% +$20.8K 3.44% 4
2023
Q1 		$13.1M Buy
157,316
+1,078
+0.7% +$89.3K 4.21% 4
2022
Q4 		$13.4M Buy
156,238
+10,290
+7% +$815K 4.87% 3
2022
Q3 		$9M Buy
145,948
+1,338
+0.9% +$84.4K 3.6% 4
2022
Q2 		$8.94M Buy
144,610
+1,791
+1% +$111K 3.58% 4
2022
Q1 		$8.49M Hold
142,819
– – 2.76% 7
2021
Q4 		$10.4M Sell
142,819
-7,500
-5% -$517K 3.22% 5
2021
Q3 		$10.5M Buy
150,319
+1,873
+1% +$132K 3.71% 4
2021
Q2 		$10.2M Buy
148,446
+50,700
+52% +$3.39M 3.78% 5
2021
Q1 		$6.32M Hold
97,746
– – 2.46% 14
2020
Q4 		$5.7M Hold
97,746
– – 2.74% 13
2020
Q3 		$6.18M Buy
97,746
+100
+0.1% +$6.93K 2.95% 9
2020
Q2 		$7.23M Buy
+97,646
New +$7.48M 3.68% 8

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Opes Wealth Management's GILD Position: Q1 2026 in Review

Opes Wealth Management held its Gilead Sciences (GILD) position steady in Q1 2026 at 169,652 shares worth $23.6M. The position accounts for 3.89% of the portfolio, ranked #4.

Opes Wealth Management first reported a position in GILD in Q2 2020 and has held it in 24 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Opes Wealth Management held 169,652 shares of Gilead Sciences worth $23.6M as of Q1 2026.
  • Opes Wealth Management left its Gilead Sciences share count unchanged in Q1 2026.
  • Gilead Sciences made up 3.89% of Opes Wealth Management's portfolio in Q1 2026, its #4 holding.
  • Opes Wealth Management first reported a position in Gilead Sciences in Q2 2020 and has held it in 24 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Opes Wealth Management's 13F filing for Q1 2026, filed 29 Apr 2026.